MEDIS TECHNOLOGIES LTD
8-A12G, 2000-04-19
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: OAKWOOD MORTGAGE INVESTORS INC OMI TRUST 1999-C, 8-K, 2000-04-19
Next: LAPITOS ACQUISITION CORP, 8-K, 2000-04-19




<PAGE>

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                             ----------------------

                                    FORM 8-A
                FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
                    PURSUANT TO SECTION 12(B) OR 12(G) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                             ----------------------
                             MEDIS TECHNOLOGIES LTD.
             (Exact Name of Registrant as Specified in Its Charter)

                DELAWARE                                 13-3669062
(State of Incorporation or Organization)              (I.R.S. Employer
                                                      Identification no.)

                                805 THIRD AVENUE
                            NEW YORK, NEW YORK 10022
               (Address of Principal Executive Offices) (Zip Code)

                             ----------------------

         If this form relates to the registration of a class of securities
pursuant to Section 12(b) of the Exchange Act and is effective pursuant to
General Instruction A.(c), check the following box. |_|

         If this form relates to the registration of a class of securities
pursuant to Section 12(g) of the Exchange Act and is effective pursuant to
General Instruction A.(d), check the following box. |X|

         Securities Act registration statement file number to which this form
relates: 333-83945

         Securities to be registered pursuant to Section 12(b) of the Act:

       Title of Each Class                    Name of Each Exchange on Which
       to be so Registered                    Each Class is to be Registered
       -------------------                    ------------------------------
          Not Applicable                              Not Applicable

        Securities to be registered pursuant to Section 12(g) of the Act:

                     COMMON STOCK, PAR VALUE $0.01 PER SHARE


<PAGE>



                 INFORMATION REQUIRED IN REGISTRATION STATEMENT

ITEM 1.  DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.

         A description of the common stock, par value $0.01 per share (the
"Common Stock"), of Medis Technologies Ltd. (the "Registrant") will be contained
in a prospectus, constituting part of the Registrant's Registration Statement on
Form S-1 (File No. 333-83945) relating to the Common Stock, to be filed pursuant
to Rule 424(b) under the Securities Act of 1933, as amended (such prospectus as
filed pursuant to Rule 424(b), the "Prospectus"). The description of the Common
Stock contained in the Prospectus is hereby incorporated by reference into this
Form 8-A.

ITEM 2.  EXHIBITS.


EXHIBIT NUMBER        DESCRIPTION
- --------------        -----------
3.1                   Restated Certificate of Incorporation of the Registrant*

3.2                   Restated By-Laws of the Registrant*

4.1                   Form of certificate evidencing shares of Common Stock*

*  Denotes document filed or to be filed as an exhibit to the Registrant's
   Registration Statement on Form S-1 (File No. 333-83945) and
   incorporated herein by reference.


<PAGE>


                                    SIGNATURE

         Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, as amended, the registrant has duly caused this registration
statement to be signed on its behalf by the undersigned, thereto duly
authorized.

                                 MEDIS TECHNOLOGIES LTD.


                                 By:    /s/ Robert K. Lifton
                                     ----------------------------------
                                            Robert K. Lifton
                                            Chairman and Chief Executive Officer

Date:   April 18, 2000




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission